Kansas City, MO,
27
November
2018
|
05:45 PM
Europe/Amsterdam

Dr. Ann Davis Awarded $2.2 Million NIH Grant

Research Collaboration Addresses Feeding Problems of Children with Chronic Medical Conditions

Ann Davis, PhD, MPH, ABPP, Director of the Center for Children’s Healthy Lifestyles & Nutrition and Ralph L. Smith Professor of Pediatrics at KU Medical Center, has been awarded a $2.2 million, five-year grant from the National Institutes of Health. Investigators from Children’s Mercy Kansas City, KU Medical Center, Children’s Hospital New Orleans and Rady Children’s Hospital in San Diego will investigate “The Safety and Efficacy of Megesterol as Part of an Outpatient Feeding Protocol for Children with Chronic Medical Conditions.” 

The purpose of the study is to assess the effectiveness of iKanEat, an outpatient multicomponent treatment designed to transition children from tube to oral feeding, specifically conducting a randomized controlled trial of a medication called megesterol that is a component of the treatment. 

“We are excited about this opportunity to examine additional options for families facing the challenges of managing a child with tube feeding and transitioning a child from tube to oral feeding,” said Dr. Davis, the principal investigator on the study. “Our team developed a novel, interdisciplinary outpatient protocol for transitioning children from tube to oral feeding called iKanEat. We are grateful for the support of the NIH to carry out this important work that is designed to improve the quality of lives for parents and medically compromised children.”

Sarah Edwards, DO, Pediatric Gastroenterology, is the PI at Children’s Mercy. Jose Cocjin, MD, Pediatric Gastroenterology, is a co-investigator, and Kelsey Dean, MS, RD, LD, CCRP, is the project coordinator.

About Us

Children’s Mercy Kansas City is ranked as one of “America's Best Children's Hospitals” in all 10 specialties rated by U.S. News & World Report and has received MagnetTM recognition for excellence in nursing services four consecutive times. With 366 licensed beds and a medical staff of more than 750 pediatric subspecialists, we care for children from all 50 states and from around the world. In addition, our leadership in pediatric genomic medicine and individualized pediatric therapeutics is driving research and innovation in neonatology, nephrology, endocrinology, gastroenterology, neurology, heart, cancer and other subspecialties to transform outcomes for children. Children’s Mercy is also nationally recognized for innovation in psychosocial care and creating a family-centered environment focused on the unique needs of hospitalized children and their families. Our love for children powers everything we do, inspiring our research, innovations and our everyday care. Because love has no limits. And with it, neither do we.